Zelira Therapeutics Limited announced Mr. Greg Blake has been promoted from VP - Global Head of Commercial and Partnering to Executive Director effective 20 February 2023. Mr. Blake has been employed by Zelira since 2020. Greg brings extensive commercial and operational leadership experience in the pharmaceutical and biotech sectors both within Australia and internationally. Greg has led the strategic development and commercialisation of a number of products across a range of therapeutic categories. Throughout his near 20 years working in healthcare Greg has built a solid foundation of knowledge across marketing and the entire commercial value chain. His work with Rhythm Biosciences as General Manager led the company through the establishment of the pre-launch critical pathway and commercialisation planning for both domestic and international markets. As Marketing Lead (Europe) with Mundipharma International, Greg successfully led 26 European countries through the pre-launch and launch phases for a novel pain medication.
Greg has held leadership roles at large multinationals (J&J and CSL) and publicly-listed biotech start-ups.